Sustained and profound analgesic benefits in people with osteoarthritis of the knee using FX006, an intra-articular extended-release formulation of triamcinolone acetonide: Results from a double-blind, randomized, parallel-group, dose-ranging study P.G. Conaghan, S. Cohen, J. Jordan, F. Berenbaum, J. Lufkin, C. Wilwerth, M. Clayman, M.K. Doyle, N. Bodick Osteoarthritis and Cartilage Volume 24, Pages S49-S50 (April 2016) DOI: 10.1016/j.joca.2016.01.113 Copyright © 2016 Terms and Conditions
Figure Average change from baseline in weekly mean of average daily pain intensity (MMRM). * P<.05 compared with placebo. Osteoarthritis and Cartilage 2016 24, S49-S50DOI: (10.1016/j.joca.2016.01.113) Copyright © 2016 Terms and Conditions